glp 1 mechanism of action diagram What is GLP-1 and Its Receptor Agonists? Graphical presentation of the mechanism

Since obesity is considered a chronic condition, many individuals may require continued care to achieve sustained weight loss and its associated health benefits 13

For the GLP-1 Booster, some users also experience mild nausea or digestive sensitivity due to the Berberine content

Use of twice-daily exenatide in basal insulintreated patients with type 2 diabetes: a randomized, controlled trial

Stomach problems, sometimes severe, have been reported in people who use RYBELSUS

Additionally, in a phase 2 trial targeting type 2 diabetes, retatrutide demonstrated significant improvements in glycemic control and substantial weight reduction, maintaining a safety profile comparable to certain approved GLP-1RAs 8 (Supplementary Table S1)